Table 3 TEAEs that occurred in 5% or more of the subjects in the study
System organ class | Placebo, n = 410 | GV-971 900 mg, n = 407 | ||
|---|---|---|---|---|
Number of events | n (%) | Number of events | n (%) | |
Infectious and infectious diseases | ||||
Urinary tract infection | 45 | 40 (9.8%) | 31 | 30 (7.4%) |
Nasopharyngitis | 26 | 23 (5.6%) | 34 | 30 (7.4%) |
Upper respiratory tract infection | 36 | 30 (7.3%) | 29 | 23 (5.7%) |
Various types of inspection | ||||
Elevated blood glucose | 30 | 29 (7.1%) | 32 | 28 (6.9%) |
Various nervous system diseases | ||||
Dizzy | 28 | 24 (5.9%) | 26 | 23 (5.7%) |
Metabolic and nutritional diseases | ||||
Hyperlipidemia | 15 | 14 (3.4%) | 29 | 29 (7.1%) |